These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34244326)

  • 1. Serum Biomarkers of Iron Stores Are Associated with Increased Risk of All-Cause Mortality and Cardiovascular Events in Nondialysis CKD Patients, with or without Anemia.
    Guedes M; Muenz DG; Zee J; Bieber B; Stengel B; Massy ZA; Mansencal N; Wong MMY; Charytan DM; Reichel H; Waechter S; Pisoni RL; Robinson BM; Pecoits-Filho R;
    J Am Soc Nephrol; 2021 Aug; 32(8):2020-2030. PubMed ID: 34244326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease.
    Eisenga MF; Nolte IM; van der Meer P; Bakker SJL; Gaillard CAJM
    BMC Nephrol; 2018 Sep; 19(1):225. PubMed ID: 30208847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum biomarkers of iron stores are associated with worse physical health-related quality of life in nondialysis-dependent chronic kidney disease patients with or without anemia.
    Guedes M; Muenz D; Zee J; Lopes MB; Waechter S; Stengel B; Massy ZA; Speyer E; Ayav C; Finkelstein F; Sesso R; Pisoni RL; Robinson BM; Pecoits-Filho R
    Nephrol Dial Transplant; 2021 Aug; 36(9):1694-1703. PubMed ID: 33624825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease.
    Awan AA; Walther CP; Richardson PA; Shah M; Winkelmayer WC; Navaneethan SD
    Nephrol Dial Transplant; 2021 Jan; 36(1):129-136. PubMed ID: 31641775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?
    Stancu S; Bârsan L; Stanciu A; Mircescu G
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):409-16. PubMed ID: 20019121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiological spectrum of anemia in non-dialysis-dependent chronic kidney disease: A single-center study from India.
    Vikrant S
    Saudi J Kidney Dis Transpl; 2019; 30(4):932-942. PubMed ID: 31464252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of markers of iron stores with outcomes in patients with nondialysis-dependent chronic kidney disease.
    Kovesdy CP; Estrada W; Ahmadzadeh S; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):435-41. PubMed ID: 19118116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma neutrophil gelatinase-associated lipocalin is associated with iron status in anemic patients with pre-dialysis chronic kidney disease.
    Kim IY; Kim JH; Lee DW; Lee SB; Rhee H; Song SH; Seong EY; Kwak IS
    Clin Exp Nephrol; 2018 Feb; 22(1):28-34. PubMed ID: 28389813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron Deficiency Anemia in Chronic Kidney Disease.
    Gafter-Gvili A; Schechter A; Rozen-Zvi B
    Acta Haematol; 2019; 142(1):44-50. PubMed ID: 30970355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.
    Block GA; Fishbane S; Rodriguez M; Smits G; Shemesh S; Pergola PE; Wolf M; Chertow GM
    Am J Kidney Dis; 2015 May; 65(5):728-36. PubMed ID: 25468387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased NGAL level associated with iron store in chronic kidney disease with anemia.
    Xiang D; Wang X; Liu P; Pan Y; Zhang Q; Chi X; Jing Y; Duan X; Wei Q; Wang J; Li M; Wang C
    Clin Exp Med; 2018 Nov; 18(4):563-568. PubMed ID: 29909502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achievement of renal anemia KDIGO targets by two different clinical strategies - a European hemodialysis multicenter analysis.
    Drozdz M; Weigert A; Silva F; Frazão J; Alsuwaida A; Krishnan M; Kleophas W; Brzosko S; Johansson FK; Jacobson SH
    BMC Nephrol; 2019 Jan; 20(1):5. PubMed ID: 30616548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low serum iron is associated with anemia in CKD stage 1-4 patients with normal transferrin saturations.
    Yu PH; Lin MY; Chiu YW; Lee JJ; Hwang SJ; Hung CC; Chen HC
    Sci Rep; 2021 Apr; 11(1):8343. PubMed ID: 33863963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting response and tolerability to ferumoxytol in nondialysis chronic kidney disease patients.
    Fishbane S; Bolton WK; Winkelmayer WC; Strauss W; Li Z; Pereira BJ
    Clin Nephrol; 2012 Sep; 78(3):181-8. PubMed ID: 22874106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004.
    Fishbane S; Pollack S; Feldman HI; Joffe MM
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):57-61. PubMed ID: 18987297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different Effects of Iron Indices on Mortality in Patients With Autosomal Dominant Polycystic Kidney Disease After Long-Term Hemodialysis: A Nationwide Population-Based Study.
    Yeh SC; Lin YC; Hong YC; Hsu CC; Lin YC; Wu MS
    J Ren Nutr; 2019 Sep; 29(5):444-453. PubMed ID: 30683605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High ferritin and low transferrin saturation are associated with pre-diabetes among a national representative sample of U.S. adults.
    Cheung CL; Cheung TT; Lam KS; Cheung BM
    Clin Nutr; 2013 Dec; 32(6):1055-60. PubMed ID: 23312547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical re-evaluation of the identification of iron deficiency states and effective iron repletion strategies in patients with chronic heart failure.
    Packer M; Anker SD; Butler J; Cleland JGF; Kalra PR; Mentz RJ; Ponikowski P; Talha KM
    Eur J Heart Fail; 2024 Jun; 26(6):1298-1312. PubMed ID: 38727791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients.
    Prats M; Font R; García C; Muñoz-Cortés M; Cabré C; Jariod M; Romeu M; Giralt M; Martinez-Vea A
    Clin Nephrol; 2014 Jun; 81(6):419-26. PubMed ID: 24691014
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.